Invest now
Gland Pharma Profit & Loss Annual
BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | Sector: Biotechnology & Drugs2,841.90 -17.00 (-0.59%)Updated : 19 Aug 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 5,248.74 | 4,725.42 | 4,676.22 | 2,802.95 |
| Other Net | -6.07 | -18.79 | -3.08 | -0.11 |
| Diluted Weighted Average Shares | 16.50 | 16.47 | 16.47 | 16.47 |
| Gain( Loss)on Saleof Assets | -0.38 | -0.03 | 0.25 | -0.08 |
| Depreciation/ Amortization | 423.67 | 377.87 | 344.57 | 146.74 |
| Operating Income | 1,181.92 | 891.08 | 988.51 | 821.65 |
| Net Income | 1,027.32 | 698.53 | 772.46 | 781.04 |
| Income Availableto Com Excl Extra Ord | 1,027.32 | 698.53 | 772.46 | 781.04 |
| Other Operating Expenses Total | 50.61 | 42.33 | 55.40 | 9.73 |
| Net Income Before Taxes | 1,464.58 | 1,062.66 | 1,132.54 | 1,054.58 |
| Net Income After Taxes | 1,027.32 | 698.53 | 772.46 | 781.04 |
| Income Availableto Com Incl Extra Ord | 1,027.32 | 698.53 | 772.46 | 781.04 |
| Costof Revenue Total | 2,501.87 | 2,338.02 | 2,461.27 | 1,858.16 |
| Gross Profit | 3,928.78 | 3,278.48 | 3,203.45 | 1,766.45 |
| Interest Inc( Exp) Net- Non- Op Total | 289.12 | 190.40 | 146.86 | 233.12 |
| Unusual Expense( Income) | 24.35 | 1.82 | 0.00 | 62.79 |
| Diluted Net Income | 1,027.32 | 698.53 | 772.46 | 781.04 |
| DPS- Common Stock Primary Issue | 20.00 | 18.00 | 20.00 | - |
| Provisionfor Income Taxes | 437.26 | 364.13 | 360.08 | 273.54 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 1,027.32 | 698.53 | 772.46 | 781.04 |
| Total Revenue | 6,430.65 | 5,616.50 | 5,664.72 | 3,624.60 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 6,430.65 | 5,616.50 | 5,664.72 | 3,624.60 |
| Selling/ General/ Admin Expenses Total | 2,192.03 | 1,932.08 | 1,782.95 | 685.17 |
| Diluted Normalized EPS | 63.33 | 42.47 | 46.88 | 50.26 |
| Research Development | 56.23 | 33.28 | 32.03 | 40.38 |
| Diluted EPS Excluding Extra Ord Items | 62.28 | 42.40 | 46.89 | 47.43 |
*All figures in crores except per share values
Gland Pharma Quick Links
Gland Pharma Dividend Gland Pharma Bonus Gland Pharma News Gland Pharma AGM Gland Pharma Rights Gland Pharma Splits Gland Pharma Board Meetings Gland Pharma Key Metrics Gland Pharma Shareholdings Gland Pharma Balance Sheet Gland Pharma Cashflow Gland Pharma Q1 Results Gland Pharma Q2 Results Gland Pharma Q3 Results Gland Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,322.50+22.50(1.73%)
320.20+4.20(1.33%)
392.05+4.75(1.23%)
262.45-5.35 (-2.00%)
1,078.60-14.35 (-1.31%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.